Abbott has agreed to pay nearly $385 million to resolve alleged false claims involving infant formula made at its Michigan facility. The settlement follows the company’s 2022 recall and plant closure amid contamination concerns. Abbott maintains that no distributed infant formula tested positive for Cronobacter and says government testing found no bacteria in unopened products.
A growing number of housing developments are running past their scheduled completion dates, leading to…
In a significant move, Chennai and Kallakurichi police have initiated legal proceedings against three DMK…
Supratiek Shyamal Ghosh: The Man Behind Aurko, The Vision Behind ALIVE INDIA thewire.in
Accenture Federal Services will pay twenty-five million dollars to settle claims. The company allegedly violated…
In a remarkable achievement, Indian-origin nurse Agimol Pradeep has clinched the Aster Guardians Global Nursing…